ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
-20.31%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$116M
AUM Growth
+$116M
(-53%)
Cap. Flow
-$74.4M
Cap. Flow
% of AUM
-64%
Top 10 Holdings %
Top 10 Hldgs %
87.62%
Holding
29
New
2
Increased
7
Reduced
6
Closed
7
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$7.05M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$4.99M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.03M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$872K |
| 5 |
ACER
Acer Therapeutics Inc. Common Stock (DE)
ACER
|
$679K |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$23.6M |
| 2 |
Arrowhead Research
ARWR
|
$14.9M |
| 3 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
$9.3M |
| 4 |
Veracyte
VCYT
|
$8.18M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$7.07M |
Sector Composition
| 1 | Healthcare | 93.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $26.7M | 20.38% | 3,019,201 +796,500 | +36% | +$7.05M |
|
2
Assembly Biosciences
ASMB
$190M
| $16.3M | 12.4% | 718,500 -211,500 | -23% | -$4.78M |
|
|
KDMN
3
DELISTED
Kadmon Holdings, Inc.
KDMN
| $15.7M | 11.96% | 7,538,000 +143,000 | +2% | +$297K |
|
|
CASM
4
DELISTED
CAS Medical Systems, Inc.
CASM
| $8.42M | 6.42% | 5,263,508 | – | – |
|
|
BHVN
5
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.93M | 5.29% | 187,500 +55,000 | +42% | +$2.03M |
|
|
AMRN
6
Amarin Corp
AMRN
$311M
| $5.95M | 4.54% | 437,500 +366,500 | +516% | +$4.99M |
|
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| $5.71M | 4.35% | 400,000 -1,655,500 | -81% | -$23.6M |
|
|
8
Veracyte
VCYT
$2.39B
| $5.57M | 4.25% | 442,500 -650,000 | -59% | -$8.18M |
|
9
IRIDEX
IRIX
$22.8M
| $5.52M | 4.21% | 1,174,500 -773,000 | -40% | -$3.63M |
|
10
argenx
ARGX
$43.6B
| $5.09M | 3.88% | 53,000 -52,000 | -50% | -$5M |
|
|
11
KalVista Pharmaceuticals
KALV
$678M
| $3.42M | 2.61% | 173,000 +44,156 | +34% | +$872K |
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $3.39M | 2.59% | 537,500 +55,000 | +11% | +$347K |
|
|
ACER
13
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $2.88M | 2.19% | 143,000 +33,730 | +31% | +$679K |
|
|
CEMI
14
DELISTED
Chembio diagnostics, Inc.
CEMI
| $2.19M | 1.67% | 387,167 -1,643,366 | -81% | -$9.3M |
|
|
VRAY
15
DELISTED
ViewRay, Inc.
VRAY
| $1.89M | 1.44% | 311,500 | – | – |
|
16
Sutro Biopharma
STRO
$72.7M
| $410K | 0.31% | +45,500 | New | +$410K |
|
17
BioCryst Pharmaceuticals
BCRX
$1.74B
| $202K | 0.15% | +25,000 | New | +$202K |
|
18
Outlook Therapeutics
OTLK
$37.8M
| $15K | 0.01% | 29,082 | – | – |
|
|
19
Arrowhead Research
ARWR
$3.05B
| – | – | -775,000 | Closed | -$14.9M |
|
20
Ascendis Pharma
ASND
$11.8B
| – | – | -71,500 | Closed | -$5.07M |
|
21
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| – | – | -353,500 | Closed | -$5.83M |
|
22
Dianthus Therapeutics
DNTH
$759M
| – | – | -170,000 | Closed | -$2.04M |
|
|
23
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – | -33,000 | Closed | -$7.07M |
|
24
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – | 0 | – | – |
|
25
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|